eNOS3 - As One Of The Genetic Aspects Of The Development Of Chronic Kidney Disease
Keywords:
chronic kidney disease, endothelin-1, gene, polymorphismAbstract
Chronic kidney disease (CKD) affects approximately 10% of the global adult population. Various genetic and environmental risk factors contribute to kidney disease, complicating the identification of underlying pathophysiologic mechanisms. CKD is based on the development of nodular or diffuse glomerulosclerosis, with its terminal stage characterized by chronic renal failure (CRF). This article discusses the clinical and genetic aspects of CKD and their relationships in the early stages of the disease, as well as the cumulative effect of metabolic, hemodynamic, and genetic factors on disease development.
References
Иванов Д. Д. Хроническая болезнь почек и хроническая почечная недостаточность у детей //
Нефрология. 2006;10;(3):100–126.
Костюшина И. С., Комарова О. В., Мазо А. М., и др. Роль показателей центральной гемодинамики,
толщины комплекса интима-медиа и эндотелиальной дисфункции у детей с ренальной артериальной
гипертензией//Педиатрическая фармакология. 2013;10(3):32–37.
Паунова С. С. Патогенетические основы нефросклероза (обзор литературы)//Нефрология и диализ.
;7(2):130–135.
Пушкарева Т. А., Корякина Л. Б., Рунович А. А., и др. Критерии оценки дисфункции эндотелия
артерий и пути ее коррекции (обзор литературы)//Клиническая лабораторная диагностика. 2008;(5):3–
Сивцева Е. М. Роль эндотелиальной дисфункции в прогрессировании хронических заболеваний
почек у детей//Российский вестник перинатологии и педиатрии. 2011;(1):47–53.
Смирнов А. В., Шилов Е. М., Добронравов В. А., и др. Национальные рекомендации. Хроническая
болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы
к лечению//Клиническая нефрология. 2012;(4):4–26.
Смыр К. В., Щербак А. В., Козловская Л. В. и др. Значение маркеров эндотелиальной дисфункции
и гемореологических нарушений для оценки активности и прогноза хронического
гломерулонефрита//Терапевтический архив. 2010;(1):47–51.
Турсунова Л., Жаббаров О. Применения сакубитрил//валсартана у больных с сердечной
недостаточностью с низкой фракцией выброса. – 2023.
Colombo M.G., Paradossi U., Andreassi M.G., et al. Endothelial nitric
oxide synthase gene polymorphisms and risk of coronary artery disease//Clinical
Chemistry. 2003. Vol. 49, No3. P. 389-395.
Coresh J. Update on the Burden of CKD. J Am Soc Nephrol. 2017;28(4): 1020–1022.
Eckardt KU, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to
global health burden. Lancet. 2013; 382(9887):158–169.
Eddy A. A. Molecular basis of renal fibrosis. Pediatr Nephrol. 2000; 15(3–4):290–301.
Ezzidi I., Mtiraoui N., Mohamed M.B., et al. Association of endothelial nitric oxide synthase Glu298Asp,
b/a, and -786T>C gene variants with diabetic nephropathy//Journal of Diabetes and its Complications. 2008.
Vol.22, No5. P. 331-338
Fogo AB, Kon V. Th e glomerulus — a view from the inside — the endothelial cell. Int J Biochem Cell
Biol. 2010;42(9):1388–1397.
Hogas SM, Voroneanu L, Serban DN, et al. Methods and potential biomarkers for the evaluation of
endothelial dysfunction in chronic kidney disease: a critical approach. J Am Soc Hypertens. 2010;4(3):116–
Hsu C. Y. Where is the epidemic in kidney disease? J Am Soc Nephrol. 2010;21(10):1607–1611.
Jabbarov O. O. et al. Disorders Function of the Heart and Kidney in Diabetes Mellitus. – 2023.
Jabbarov, O. O., A. A. Imamov, N. K. Khuzhaniyazova, L. D. Tursunova, and O. Atakhanova Sh.
"Pathogenetic Factors Development of Diabetic Nephropathy." (2023).
Kidney disease: Improving Global Outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice
guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing
gaps in care, research, and policy. Lancet. 2017;390(10105):1888–1917.
Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clin Chim Acta.
;411(19–20):1412–1420
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
